abstract |
The present invention provides isolated alpha and beta chains of a T Cell Receptor (TCR) specific for an EBV antigen. The invention also describes TCRs having the alpha and beta chains and methods of making and using the same, e.g., cellular immunotherapy in a subject having an EBV-associated disease, disorder or condition. |